Djukić Aleksandar, Zivancević-Simonović Snezana, Djurdjević Predrag, Arsenijević Nebojsa
Srp Arh Celok Lek. 2006 Jul-Aug;134(7-8):290-4. doi: 10.2298/sarh0608290d.
It is known that hyperthyroidism as well as thyrosuppressive therapy can influence the cells of immunological system.
To examine the function of phagocyte cells in persons with hyperthyroidism and to examine if propylthiouracil (PTU) influences this function.
The study included 15 patients with hyperthyroidism and 10 healthy persons. The parameters of phagocytic activity of mononuclear and polymorphonuclear leucocytes were tested by method of ingestion of particles of inactivated yeast labeled with neutral-red.
It was demonstrated that patients with hyperthyroidism, before the onset of therapy as well as 14 days after introduction of PTU, had decreased number of leucocytes (before PTU: 6.7 +/- 3.2 x 10(9)/l, after PTU: 6.1 +/- 2.0 x 10(9)/l and control: 8.0 +/- 1.6 x 10(9)/l; p=0.039), PMN leucocytes (before PTU: 3.9 +/- 2,4 x 10(9)/l, after PTU: 3.5 +/- 1.6 x 10(9)/l and control: 4.8 +/- 0.9 x 10(9)/l; p=0.037) and number of phagocyte PMN cells (before PTU: 0.9 +/- 0.9 x 10(9)/l, after PTU: 0.9 +/- 0.7 x 10(9)/l and control: 1.3 +/- 0.6 x 10(9)/l; p<0,05), but they had increased index of phagocytosis (before PTU: 2.0 +/- 0.2, after PTU: 1.9 +/- 0.2 and control: 1.7 +/- 0.2; p=0.029), while capacity of phagocytosis remained unchanged (before PTU: 1.9 +/- 1.7 x 10(9)/l, after PTU: 1.6 +/- 1.9 x 10(9)/l and control: 2.4 +/- 1.4 x 10(9)/l; p>0.05). The number of mononuclear leucocytes and parameters of phagocytic activity of mononuclear phagocytes in persons with hyperthyroidism did not change significantly in comparison with the control group.
Patients with hyperthyroidism had decreased number of leucocytes, PMN leucocytes and number of phagocyte PMN cells, and increased index of phagocytosis, while capacity of phagocytosis remained unchanged. The number and parameters of phagocytic activity of mononuclear leucocytes did not change. PTU therapy had no effect on the examined parameters.
众所周知,甲状腺功能亢进症以及甲状腺抑制疗法会影响免疫系统细胞。
研究甲状腺功能亢进症患者吞噬细胞的功能,并探究丙硫氧嘧啶(PTU)是否会影响该功能。
该研究纳入了15例甲状腺功能亢进症患者和10名健康人。通过摄入用中性红标记的灭活酵母颗粒的方法,检测单核细胞和多形核白细胞的吞噬活性参数。
结果表明,甲状腺功能亢进症患者在治疗开始前以及引入PTU 14天后,白细胞数量减少(PTU治疗前:6.7±3.2×10⁹/L,PTU治疗后:6.1±2.0×10⁹/L,对照组:8.0±1.6×10⁹/L;p = 0.039),中性粒细胞数量减少(PTU治疗前:3.9±2.4×10⁹/L,PTU治疗后:3.5±1.6×10⁹/L,对照组:4.8±0.9×10⁹/L;p = 0.037),吞噬性中性粒细胞数量减少(PTU治疗前:0.9±0.9×10⁹/L,PTU治疗后:0.9±0.7×10⁹/L,对照组:1.3±0.6×10⁹/L;p<0.05),但吞噬指数增加(PTU治疗前:2.0±0.2,PTU治疗后:1.9±0.2,对照组:1.7±0.2;p = 0.029),而吞噬能力保持不变(PTU治疗前:1.9±1.7×10⁹/L,PTU治疗后:1.6±1.9×10⁹/L,对照组:2.4±1.4×10⁹/L;p>0.05)。与对照组相比,甲状腺功能亢进症患者的单核细胞数量和单核吞噬细胞的吞噬活性参数没有显著变化。
甲状腺功能亢进症患者白细胞、中性粒细胞和吞噬性中性粒细胞数量减少,吞噬指数增加,而吞噬能力保持不变。单核细胞数量和吞噬活性参数没有变化。PTU治疗对所检测的参数没有影响。